Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03383081
PHASE2

The Safety/Efficacy of hUC Mesenchymal Stem Cells(19#iSCLife®-OA) Therapy for Patients With Osteoarthritis

Sponsor: Sclnow Biotechnology Co., Ltd.

View on ClinicalTrials.gov

Summary

The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Osteoarthritis, and in addition, provide basis for exploring the treatment regimen of UC-MSC therapy in different degree of cartilage defect disease

Official title: A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cells(19#iSCLife®-OA) Therapy for Patients With Osteoarthritis

Key Details

Gender

All

Age Range

Any - 70 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2018-10-01

Completion Date

2026-12-31

Last Updated

2025-12-04

Healthy Volunteers

No

Interventions

BIOLOGICAL

Low dose mesenchymal stem cells

Human umbilical cord mesenchymal stem cells (SCLnow 19#): group A, 1 \* 10\^7 cells (5ml);

BIOLOGICAL

High dose mesenchymal stem cells

Human umbilical cord mesenchymal stem cells (SCLnow 19#): group B, 2 \* 10\^7 cells (5ml)

PROCEDURE

Intraarticular injection

Intraarticular injection with human umbilical cord mesenchymal stem cells (SCLnow 19#) with different dose group

Locations (1)

Xiangya Hospital Central South University

Changsha, Hunan, China